Vlad Coric
CIK 1704317 · Chief Executive Officer · last filed 2026-06-08
Vlad Coric is a Chief Executive Officer who has filed 40 SEC Form 4 insider transactions across 4 companies since 2017. The most recent filing, for RPRX, was dated Jun 8, 2026. Across all open-market trades the lifetime net is +$28.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $86.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$86.36M
4
40
$28.52M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RPRX | Director | 15,343 | $62.32 | $956.2K | $0 | 3 | 2026-06-08 |
| BHVN | Chief Executive Officer | 3,006,673 | $15.74 | $47.33M | $26.52M | 30 | 2026-03-03 |
| MANE | Director | 390,514 | $97.51 | $38.08M | $2.00M | 1 | 2026-02-05 |
| Revance Therapeutics, Inc. (RVNC) Delisted | Director | 15,000 | $3.65 | $54.8K | $0 | 4 | 2025-02-06 |
Recent Filings
40 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-08 | RPRX | Grant (A) | +4,545 | $0 | EDGAR |
| 2026-03-03 | BHVN | Grant (A) | — | $0 | EDGAR |
| 2026-02-05 | MANE | Mixed | +755,908 | $2.00M | EDGAR |
| 2026-01-07 | BHVN | Mixed | +6,820 | -$73.8K | EDGAR |
| 2025-11-17 | BHVN | Buy (P) | +666,666 | $5.00M | EDGAR |
| 2025-05-14 | RPRX | Grant (A) | +7,614 | $0 | EDGAR |
| 2025-04-21 | RPRX | Grant (A) | +3,184 | $0 | EDGAR |
| 2025-02-06 | Revance Therapeutics, Inc. (RVNC) Delisted | Mixed | −20,784 | -$21.1K | EDGAR |
| 2025-01-07 | BHVN | Mixed | +7,445 | -$262.9K | EDGAR |
| 2024-10-03 | BHVN | Buy (P) | +21,052 | $1000.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.